TREA

88521914 - POLYTAXEL

Follow

Information

  • Trademark
  • 88521914
  • Serial Number
    88521914
  • Registration Number
    6770342
  • Filing Date
    July 18, 2019
    5 years ago
  • Registration Date
    June 28, 2022
    2 years ago
  • Transaction Date
    April 19, 2023
    2 years ago
  • Status Date
    June 28, 2022
    2 years ago
  • Published for Opposition Date
    April 12, 2022
    3 years ago
  • Location Date
    April 11, 2022
    3 years ago
  • Status Code
    700
  • Current Location
    TMEG LAW OFFICE 105
    Employee Name
    VALLILLO, MELISSA C
  • Attorney Docket Number
    12291814US01
    Attorney Name
    Samuel S. Lee
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
POLYTAXEL
Case File Statements
  • GS0051: Pharmaceutical preparations for the treatment of pancreatic tumors; pharmaceutical agents for the treatment of disorders in sensory organs; thyroid and para-thyroid hormone preparations; medicinal tonics for the treatment of pancreatic tumors; oral contraceptive pills; antiemetics; local anesthetics; bronchodilating preparations; anti-cough drops; androgen preparations; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents for use in regulating metabolism; vaccines against flu; chilblain preparations; pharmaceutical preparations for headache; anaesthetics; pharmaceutical for use in the treating disorders of the peripheral nervous system; pharmaceutical preparations for immunity adjustment; nutritive substances for microorganisms for medical purposes; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations for treating disorders of the urogenital organs; vitamin preparations; pharmaceutical preparations for the treatment of bone diseases; anti-inflammatory and antipyretic preparations; pharmaceutical agents for treating disorders of the digestive organs; pharmaceutical preparations for the treatment of cardiovascular disorders; nervines; ophthalmic preparations; allergy medications; chemicopharmaceutical preparations for the treatment of pancreatic disorders; medicines for the treatment of gastrointestinal diseases; mineral injection preparations featuring vitamin supplements for medical purposes; antioxidants for medical purposes; haematogen; pharmaceutical preparations for tumor treatment; multivitamin preparations; suppositories; pharmaceutical preparations for use in the treatment of disorders of the central nervous system; pharmaceutical preparations for diagnosis of cancer; sedatives; analgesics; vaginal washes for medical purposes; pharmaceutical preparations for treating asthma; medicines for treating tooth pain; hemorrhoid preparations; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; vaccines against pneumococcal infections; dermatological pharmaceutical products; contraceptive preparations; antihypertensives; anti-uric preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations for treatment of hemorrhoids; antibiotic preparations; antibiotics; anti-cancer preparations; anti-cancer treatment supplements; antidepressants; anticoagulants; antineoplastics; anti-dermoinfectives; antidotes; antipyretic analgesics; febrifuges; vasoconstrictors; hypoglycemic agents; blood solvent being preparations for treating blood disorders; pharmaceutical preparations for treating disorders of the respiratory organs; respiratory stimulant preparations; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for treating respiratory diseases and asthma; mixed vitamin preparations; preparations for the treatment of burns; disinfectants for chemical toilets; chemotherapeutics; preparations for treatment of hepatitis; preparations for treating colds; preparations for the treatment of hyperlipidemia; preparations for the treatment of hypercholesteremia; pharmaceutical preparations for treating hypertension; pharmaceutical preparations for the treatment of osteoporosis; preparations for the treatment of osteoporosis; injectable pharmaceuticals for treatment of anaphylactic reactions; pharmaceutical preparations for treating halitosis; nausea treatment preparations; antiulcerants; pharmaceutical preparations for the treatment of musculoskeletal disorders; preparations for the treatment of muscle fatigue; pharmaceutical preparations for treating chloasma; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating peripheral nervous system disorders; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for the treatment of rhinitis; pharmaceutical products for the treatment of bone diseases; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; pharmaceutical preparations for the treatment of cancerous cells; medicines for treating intestinal disorders; cardiovascular treatment preparations; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of disorders of the metabolic system; pharmaceutical preparations for treating allergies; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory disorders; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; medicated preparations for the treatment of mouth disorders; transdermal patches for medical treatment of nausea; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of gout; drug delivery agents in the form of dissolvable films, coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements
Case File Event Statements
  • 4/18/2023 - 2 years ago
    42 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/18/2023 - 2 years ago
    41 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/18/2023 - 2 years ago
    40 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/18/2023 - 2 years ago
    39 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/18/2023 - 2 years ago
    38 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/18/2023 - 2 years ago
    37 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/28/2022 - 2 years ago
    36 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 6/28/2022 - 2 years ago
    35 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/12/2022 - 3 years ago
    34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/12/2022 - 3 years ago
    33 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/11/2022 - 3 years ago
    32 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 4/5/2022 - 3 years ago
    31 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 3/28/2022 - 3 years ago
    30 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 3/23/2022 - 3 years ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/21/2022 - 3 years ago
    28 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 3/14/2022 - 3 years ago
    27 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 3/7/2022 - 3 years ago
    26 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 3/5/2022 - 3 years ago
    25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/28/2022 - 3 years ago
    24 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 7/30/2021 - 3 years ago
    23 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 10/13/2020 - 4 years ago
    22 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/13/2020 - 4 years ago
    21 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/13/2020 - 4 years ago
    20 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 10/13/2020 - 4 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/13/2020 - 4 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/9/2020 - 4 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/19/2020 - 5 years ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/19/2020 - 5 years ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/19/2020 - 5 years ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/17/2020 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/17/2020 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/17/2020 - 5 years ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/16/2020 - 5 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 4/9/2020 - 5 years ago
    9 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/26/2019 - 5 years ago
    8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/26/2019 - 5 years ago
    7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/10/2019 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/10/2019 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 10/10/2019 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/7/2019 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/25/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/22/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP